SMTL ID : 6qb9.2 (1 other biounit)

Structure of an anti-Mcl1 scFv

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.85 Å

Oligo State

monomer

Ligands

2 x TLA: L(+)-TARTARIC ACID(Non-covalent)

TLA.1: 5 residues within 4Å: Chain A: S.31, S.33, S.52, S.53 Ligands: TLA.2 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:S.53, A:S.53 Water bridges: A:S.31, A:S.33, A:S.33 TLA.2: 7 residues within 4Å: Chain A: S.52, S.53, S.54, S.55, S.56, Y.57 Ligands: TLA.1 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:S.53, A:S.53, A:S.54, A:S.56, A:S.56

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Luptak, J. et al., Antibody fragments structurally enable a drug-discovery campaign on the cancer target Mcl-1. Acta Crystallogr D Struct Biol (2019)

Release Date

2019-11-06

Peptides

scFv55: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
X

scFv55

Related Entries With Identical Sequence